Cargando…
MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines
Diffuse large B-cell lymphoma (DLBCL) is the most frequent type of non-Hodgkin lymphoma. Despite a favorable therapeutic response to first-line chemo-immunotherapy, still 30–40% of patients is refractory, or relapse after this treatment. Thus, alternative strategies must be sought. Previous studies...
Autores principales: | Farina, Floriana Maria, Inguscio, Alessandra, Kunderfranco, Paolo, Cortesi, Alice, Elia, Leonardo, Quintavalle, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520941/ https://www.ncbi.nlm.nih.gov/pubmed/28640256 http://dx.doi.org/10.1038/cddis.2017.291 |
Ejemplares similares
-
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro
por: Quintavalle, Manuela, et al.
Publicado: (2010) -
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications
por: Elia, Leonardo, et al.
Publicado: (2017) -
Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma
por: Li, Jing, et al.
Publicado: (2022) -
Targeting cyclin D1 for mantle cell lymphoma
por: Chen, Jingtao
Publicado: (2015) -
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells
por: Jiang, Liling, et al.
Publicado: (2022)